November 17, 2026
Business

Delhi HC allows Dr Reddy’s to make semaglutide for export, rejects appeal(Soban News)

The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute

​The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute by Soban News (international And National News)

Related posts

As global campuses land, a churn may sweep India’s academic talent pool(Soban News)

News-Soban-Admin

PM Modi credits India’s economic growth to decade of macroeconomic stability | Latest News India – Hindustan Times – Hindustan Times

News-Soban-Admin

Address Maker, AIGPL ink ₹200 crore private credit deal to help develop real estate projects, enter Mumbai market(Soban News)

News-Soban-Admin

Leave a Comment